BOSTON – March 5, 2026 – Global law firm Greenberg Traurig, LLP was named a finalist for three 2026 Life Sciences Patent Network (LSPN) Awards, recognizing the firm’s excellence and leadership in life sciences intellectual property.
Greenberg Traurig is a finalist in the following categories:
- Best in Patent Portfolio Management
- Life Sciences Prosecution Firm of the Year
- Medical Device IP Firm of the Year
In 2025, LSPN named Greenberg Traurig the “Life Sciences Patent Strategy Firm of the Year.”
In a joint statement, David J. Dykeman and Wayne H. Elowe, co-chairs of Greenberg Traurig’s Global Life Sciences & Medical Technology Group, said: “Being named a finalist in three categories highlights Greenberg Traurig’s focus on anticipating where science, innovation, regulation, funding, and exits intersect, and crafting patent strategies that support each stage of company growth. We are proud that LSPN continues to recognize Greenberg Traurig’s leadership in life sciences IP.”
Organized by Life Sciences Intellectual Property Review, the LSPN Awards USA 2026 recognizes outstanding achievements in pharmaceutical and biotech patent protection. These awards celebrate the organizations that are pushing boundaries, delivering exceptional results, and shaping the future of life sciences IP. The full list of finalists is available here. Winners will be announced at an awards ceremony April 30 at The Hyatt Regency, Boston.